Abstract:Abstract Multidrug-resistance (MDR) is a major hindrance to successful chemotherapy. Among different mechanisms responsible for MDR, cellular over-expression of P-glycoprotein (Pgp) plays an important role. Pgp is an energy dependent drug efflux pump that effectively transports a broad of commonly used chemotherapeutic drug out of the cells and leads to resistance to the chemotherapeutic drugs. Use of modulators is main approach to overcome MDR. Although, in vitro and in vivo preclinical studies have yielded encouraging results, the clinical reversal of resistance by common modulators such as verapamil, quinine, and cyclosporine A has been difficult due to the toxic side effects. Antisense technology offers an alternative approach to overcome MDR. RNA interference (RNAi) is the best one of all antisense technologies. RNAi acts through a post-transcriptional targeting of mRNA for degradation, resulting in sequence-specific post-transcriptional gene silencing. Short hairpin RNA (shRNA) vectors can be transfected into the cells to stably express siRNA. In our preliminary study, eukaryotic shRNA expression vectors aimed at mdr1 mRNA target sequences were cloned and transfected into drug resistance cell line K562/A02 by liposome-induced gene transfection. The mdr1 mRNA was identified by real time RT-PCR, the function of P-gp was measured by a daunorubicin (DNR) efflux assay, and the sensitivity of cell lines to doxorubicin (ADM) was detected by an MTT assay. Our results showed that two mdr1-targeted shRNAs could down-regulate mdr1 mRNA and P-gp expression, with mdr1 mRNA reduced by 86% and 88%. The intracellular DNR increased after RNAi treatment, with the daunorubicin efflux ratio at 60min were 13% and 22%, compared with control (40%~45%) (P<0.05). The MTT assay demonstrated the relative reversing efficiency to doxorubicin to be 84% and 77%. Conclusion: RNA interference can effectively reverse mdr1-mediated multidrug resistance in resistant leukemic cell line.

[An Experimental Study of Recombinant Adenovirus Microsphere Carrying Antisense Multidrug Resistance-Associated Protein Gene for Reversing MRP of Hepatocellular Carcinoma in Vitro].

Mdr-1 ribozyme in the reversal of multidrug resistance in human ovarian cancer]

[Reversal of the Multidrug Resistance in Human Hepatocellular Carcinoma Cells by Recombinant Adenoviral Delivery of the MRP Antisense RNA in Vitro].

Reversal of Multidrug Resistance in Human Drug-Resistant Hepatocellular Carcinoma Cells by Recombinant Adenoviral Delivery of the Multidrug Resistance-Associated Protein Antisense RNA

Hepatic Arterial Injection of Recombinant Adenovirus Microspheres Carrying Antisense Multidrug Resistance-Associated Protein Gene for Hepatocellular Cancer in Rats

Effective Inhibition Of Cancer Cells By Recombinant Adenovirus Expressing Egfr-Targeting Artificial Microrna And Reversed-Caspase-3

Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.

Cell-Specific Expression of Artificial Micrornas Targeting Essential Genes Exhibit Potent Antitumor Effect on Hepatocellular Carcinoma Cells

[Reversal of Multidrug Resistance Gene MDR1 and MRP of Drug-Resistant Human Hepatocellular Carcinoma Cells SMMC-7721/ADM with Antisense Phosphorothioate Oligonucleotides].

The effect of miR-199a on drug resistance of hepatocellular carcinoma cells by regulating MDR1/P-gp expression

THE ROLE OF MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN IN THE FORMATION OF ADRIAMYCIN-INDUCED MULTIDRUG RESISTANCE TO HEPATOCELLULAR CANCER CELL SMMC-7721 IN HUMAN HEPATOCELLULAR CARCINOMA

Screening effective sequences of small interfering RNAs targeting mrp1 gene in human HepG2/mrp1 cells

Adriamycin induced overexpession of mdr1 gene-coded p-glycoprotein in human hepatocellular carcinoma orthotopic transplanted into nude mice

Experimental Investigation of Hepatic Arterial Embolism Treatment with Microsphere Encapsulation of Adenovirus with HSV-TK Gene

Construction of multidrug resistance hepatocellular carcinoma cell model

Suppression of Mrp1 Expression and Restoration of Sensitivity to Chemotherapy in Multidrug-Resistant Hepatocellular Carcinoma Cell Lines HepG2/mrp1 by RNA Interference in Vitro

In Vitro And In Vivo Inhibition Of Mrp Gene Expression And Reversal Of Multidrug Resistance By Sirna

Antisense MDR Oligonucleotide Combined with Chemotherapy to Inhibit Drug Resistant Tumor Cell Growth

Study On Rna Interference Reversing Multidrug Resistance In K562/A02 Resistant Leukemia Cell.

EFFECTS OF PHOSPHOROTHIOATE ANTISENSE OLIGONUCLEOTIDES TARGETING MRP Mrna ON DRUG-RESISTANT CELL LINE SMMC-7721／ADM

Short Hairpin RNA Expression Reversing MDR1 Gene-Dependent Multidrug Resistance of Human Breast Cancer Cell Line (Mcf-7/Adrr)